Programs have been developed all over the country to meet the needs of patients, families and oncology professionals, the people who deal with blood cancer every day and the people who care for them.


PROFYLE has recruited many of Canada’s leaders in pediatric, adolescent and young adult cancer research and care. Our multidisciplinary team consists of more than 50 investigators and collaborators, all working to improve the outcomes of young Canadians with high-risk cancers. In the past, if a child battling cancer lived in a region without a molecular profiling site, accessing this was not an option. PROFYLE is breaking down barriers, giving young people who need it the most access to the best cancer care in Canada. For example, a child enrolled in the study will have his or her tumor sample sent to one of three profiling sites in Canada. The results are then discussed at a molecular tumor board – and if the patient meets criteria for a clinical trial suitable for their cancer they will be enrolled.

Hope & Cope

Hope & Cope helps people cope with cancer. Guided by professional staff, cancer-experienced volunteers provide psychosocial support and practical resources that help patients regain a sense of control and well-being, reduce isolation and restore hope. Easily accessible and open to all, Hope & Cope is funded by the community and is located at the Jewish General Hospital’s Segal Cancer Centre and the Hope & Cope Cancer Wellness Centre.

BC Medical Journal

Since 1959, the British Columbia Medical Journal is a general medical journal providing continuing medical education with a focus on evidence-based medicine. The BCMJ provides clinical and review articles written primarily by BC physicians for BC physicians. It also contains editorials, BC medical news, book reviews, career opportunity and CME listings, physician profiles, and regular columns, such as those by the BC Centre for Disease Control and WorkSafeBC. Physicians debate medicine and medical politics in letters and longer essays.

National Comprehensive Cancer Network

The National Comprehensive Cancer Network is a not-for-profit alliance of 32 leading cancer centers devoted to patient care, research, and education. NCCN is dedicated to improving and facilitating quality, effective, equitable, and accessible cancer care so all patients can live better lives. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. By defining and advancing high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers around the world.

U-Link Canada was launched to improve access to clinical trials of new and innovative cancer therapies for Canadian childhood cancer patients. Given that Canada is an expansive country, patients and families may be required to travel great distances to access clinical trials. Recognizing this unique challenge, also functions as a resource to help decrease the financial burdens on patients and their caregivers when travelling for treatment.